Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
ZCCN INFO
832171
5
JILIN TANGU
836077
CN Stock MarketDetailed Quotes
301015 Qingdao Baheal Medical INC.
- 18.34
- +0.01+0.05%
Market Closed May 14 15:00 CST
9.64BMarket Cap16.33P/E (TTM)
18.42High18.09Low38.16KlotVolume18.28Open18.33Pre Close69.54MTurnover0.73%Turnover Ratio13.94P/E (Static)525.62MShares35.9052wk High4.08P/B9.64BFloat Cap17.3752wk Low22.00Limit Up525.55MShs Float53.97Historical High14.66Limit Down1.80%Amplitude16.19Historical Low0.76Dividend TTM18.23Avg Price20.84KlotAsk4.15%Div YieldTTM100Lot Size16.87KlotBid
About Qingdao Baheal Medical INC. Company
The company was founded in 2005 as a pharmaceutical industrialization platform that supports innovation at the source. Its core business focuses on product development, manufacturing and commercial operation of medical innovation achievements, and effectively optimizes medical scenarios through scientific and technological innovation. The company's main business covers the three sectors of brand operation, wholesale distribution and retail. The main products or businesses include operating DiQiao, Piter, Hailu, Astellas series, Roche series, full magnetic levitation artificial heart, ZAP-X Mars boat radiosurgery robot, Utidi and new categories of effective skincare products: Keonis, Isona, Transhino, etc., and its own brand Newt Schuma; distributes pharmaceuticals, Chinese medicine tablets, medical devices, diagnostic reagents, medical consumables; sells pharmaceuticals, medical devices, health food, cosmetics, etc. Corporate honors: Top 50 service enterprises in Shandong in 2021, the first batch of Chinese OTC brand clusters, 2021 Pharmaceutical Industry “13th Five-Year” Enterprise Management Award - Outstanding Growth Enterprise, certified by Euromonitor as “No. 1 in the domestic imported calcium supplement market for eight consecutive years”, and won the “Nursery Network” Orange Product List's Top 10 most popular single-product pharmaceuticals and nutritional products of the year.
Company Profile
Short Name-A百洋医药
Symbol-A301015
Company NameQingdao Baheal Medical INC.
Listing DateJun 30, 2021
Issue Price7.64
Shares Offered52.60M share(s)
FoundedMar 8, 2005
Legal Representativegang fu
General Managergang fu
Secretaryzhen li
Accounting FirmLixin Certified Public Accountants (Special General Partnership)
Securities Representativenina liu
Legal CounselBeijing Tianyuan Law Firm
Employees1535
Phone0532-66756688
Office AddressBuilding 1, No. 88 Tongbai Road, Shibei District, Qingdao, Shandong
Zip Code266042
Registered AddressBuilding 1, No. 88 Tongbai Road, Shibei District, Qingdao, Shandong
Fax0532-67773768
Emailbyyy@baheal.com
Websitehttp://www.baheal.cn
BusinessLicense items: drug retail; pharmaceutical wholesale; Class III medical device management; Class III medical device leasing; urban distribution and transportation services (excluding dangerous goods); Class II value-added telecommunications services; Internet information services; road cargo transportation (excluding dangerous goods). (Projects requiring approval according to law can only carry out business activities after approval by relevant departments. Specific business projects are subject to the relevant department's approval documents or licenses). General items: import and export of goods; food sales (sale of pre-packaged food only); Internet sales of food (sale of pre-packaged food only); sale of infant formula and other infant formula; sales of health food (pre-packaged); sale of formula food for special medical purposes; sale of class I medical devices; sales of class II medical devices; retail sales of sporting goods and equipment; retail of cosmetics; retail of household goods; wholesale of kitchen utensils and household goods; sale of disinfectants (excluding hazardous chemicals); sale of household appliances; repair of special equipment; leasing of Class II medical devices; low-temperature storage (not included) Dangerous chemicals, etc.); general cargo storage services (excluding hazardous chemicals, etc.); technical services, technology development, technical consulting, technical exchange, technology transfer, technology promotion; health consulting services (excluding diagnosis and treatment services); marketing planning; information consulting services (excluding licensed information consulting services); non-residential real estate leasing; technology import and export. (With the exception of projects subject to approval according to law, independently carry out business activities based on a business license in accordance with the law)
Company Executives
- Name
- Position
- Salary
- gang fu
- Chairman, Directors, General Manager, Nomination Committee Members, Strategy Committee Convener
- 3.45M
- qing song
- Directors, Strategy Committee Members, Member of the Remuneration and Assessment Committee, Audit Committee Member
- --
- yuan zhang
- Directors, Deputy General Manager
- 2.85M
- xiaowei zhu
- Directors, Deputy General Manager, Strategy Committee Members
- 3.11M
- zhen li
- Directors, Board Secretary, Deputy General Manager, Chief Financial Officer
- 44.70K
- haishen chen
- Directors
- --
- mingzhong fu
- Independent Directors, Audit Committee Members, Strategy Committee Members, Nomination Committee Convener
- 250.00K
- xianjing hao
- Independent Directors, Audit Committee Convener, Member of the Remuneration and Assessment Committee
- 250.00K
- yindi lu
- Independent Directors, Remuneration and Assessment Committee Convener, Nomination Committee Members
- 250.00K
- nina liu
- Securities Affairs Representative
- --
- jun mou
- Chairman of the Supervisory Board, Auditors
- --
- xuebiao li
- Auditors
- 1.37M
- tingwei wang
- Deputy General Manager
- 3.16M
- biquan wang
- Deputy General Manager
- 3.00M
- nan du
- Employee Supervisors
- 1.23M
Market Insights
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting